Article info
PDFResearch ethics
The evaluation of the risks and benefits of phase II cancer clinical trials by institutional review board (IRB) members: a case study
- Correspondence to: A W Musschenga Department of Philosophy, Vrije Universiteit, De Boelelaan 1105, 1081 HV Amsterdam, The Netherlands; aw.musschenga{at}mdw.vu.nl
Citation
The evaluation of the risks and benefits of phase II cancer clinical trials by institutional review board (IRB) members: a case study
Publication history
- Received August 29, 2002
- Accepted June 29, 2005
- Revised June 28, 2005
- First published February 28, 2006.
Online issue publication
April 27, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2006 by the Journal of Medical Ethics
Other content recommended for you
- Variations in institutional review board processes and consent requirements for trauma research: an EAST multicenter survey
- When are clinical trials beneficial for study patients and future patients? A factorial vignette-based survey of institutional review board members
- ‘Ethical responsibility’ or ‘a whole can of worms’: differences in opinion on incidental finding review and disclosure in neuroimaging research from focus group discussions with participants, parents, IRB members, investigators, physicians and community members
- A qualitative study of institutional review board members’ experience reviewing research proposals using emergency exception from informed consent
- How IRBs view and make decisions about coercion and undue influence
- Ethics committees for biomedical research in some African emerging countries: which establishment for which independence? A comparison with the USA and Canada
- Clinical research with economically disadvantaged populations
- Leveraging artificial intelligence to detect ethical concerns in medical research: a case study
- Developing capacity to protect human research subjects in a post-conflict, resource-constrained setting: procedures and prospects
- How US institutional review boards decide when researchers need to translate studies